The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial

BACKGROUND: Several clinical trials and recent meta-analyses have demonstrated that administration of recombinant human granulocyte-colony stimulating factor (G-CSF) is safe and, only in patients with large acute myocardial infarction (AMI), is associated with an improvement in left ventricular ejec...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Antonio Maria, D’Amario, Domenico, Teofili, Luciana, Basile, Eloisa, Cannata, Francesco, Graziani, Francesca, Marzilli, Mario, Russo, Antonio Matteo, Tarantini, Giuseppe, Ceconi, Claudio, Leone, Giuseppe, Trani, Carlo, Rebuzzi, Antonio Giuseppe, Crea, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759781/
https://www.ncbi.nlm.nih.gov/pubmed/26891753
http://dx.doi.org/10.1186/s13063-016-1172-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759781/
https://www.ncbi.nlm.nih.gov/pubmed/26891753
http://dx.doi.org/10.1186/s13063-016-1172-0

Ejemplares similares